Correction to: Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen β receptor (British Journal of Pharmacology, (2007), 152, 2, (207-215), 10.1038/sj.bjp.0707359);Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen β receptor

British Journal of Pharmacology

Volumn 152, Issue 2, 2007, Pages 207-215

  Leung, K W ^a   Cheung, L W T ^b   Pon, Y L ^b   Wong, R N S ^a   Mak, N K ^a   Fan, T P P ^c   Au, S C L ^d   Tombran Tink, J ^e,f   Wong, A S T ^b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Ginseng; Oestrogen receptor; PEDF

Indexed keywords

ANGIOGENESIS INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GINSENOSIDE RB 1; PIGMENT EPITHELIUM DERIVED FACTOR; SMALL INTERFERING RNA;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 34948887630     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.14946     Document Type: Erratum

References (41)

1. Abe R, Shimizu T, Yamagishi S, Shibaki A, Amano S, Inagaki Y et al. (2004). Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164: 1225-1232.
2. Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A et al. (2006). Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol 98: 97-110.
3. Blommel P, Hanson GT, Vogel KW (2004). Multiplexing fluorescence polarization assays to increase information content per screen: applications for screening steroid hormone receptors. J Biomol Screen 9: 294-302.
4. Brandenberger AW, Tee MK, Jaffe RB (1998). Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 83: 1025-1028.
5. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M (2002). Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 62: 4977-4984.
6. Cascio S, Bartella V, Garofalo C, Russo A, Giordano A, Surmacz E (2007). Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 282: 3498-3506.
7. Cheung LW, Au SC, Cheung AN, Ngan HY, Tombran-Tink J, Auersperg N et al. (2006). Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 147: 4179-4191.
8. Cho J, Park W, Lee S, Ahn W, Lee Y (2004). Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding. J Clin Endocrinol Metab 89: 3510-3515.
9. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu HJ, Benedict W et al. (1999). Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285: 245-248.
10. Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP et al. (2003). Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9: 774-780.
11. Duda RB, Zhong Y, Navas V, Li MZ, Toy BR, Alavarez JG (1999). American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol 72: 230-239.
12. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K et al. (2002). Pigment epithelium-derived factor suppresses ischemiainduced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 43: 821-829.
13. Ek ET, Dass CR, Choong PF (2006). PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 12: 497-502.
14. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN (2006). Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27: 297-309.
15. Folkman J (2004). Endogenous angiogenesis inhibitors. APMIS 112: 496-507.
16. Garvin S, Ollinger K, Dabrosin C (2006). Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231: 113-122.
17. Gustafsson JA (2000a). Novel aspects of estrogen action. J Soc Gynecol Invest 7: S8-S9.
18. Gustafsson JA (2000b). New insights in oestrogen receptor (ER) research - the ERbeta. Eur J Cancer 36 (Suppl. 4): S16.
19. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS (2003). Activities of estrogen receptor alpha-and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206: 13-22.
20. Helms S (2004). Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9: 259-274.
21. Kronenberg F, Fugh-Berman A (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137: 805-813.
22. Lee YJ, Jin YR, Lim WC, Park WK, Cho JY, Jang S et al. (2003). Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res 26: 58-63.
23. Li C, Tang Y, Li F, Turner S, Li K, Zhou X et al. (2006). 17beta-estradiol (betaE2) protects human retinal Muller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia 53: 392-400.
24. Madri JA, Pratt BM, Tucker AM (1988). Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106: 1375-1384.
25. Ozers MS, Ervin KM, Steffen CL, Fronczak JA, Lebakken CS, Carnahan KA et al. (2005). Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization. Mol Endocrinol 19: 25-34.
26. Pettersson K, Gustafsson JA (2001). Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63: 165-192.
27. 2+ channel currents in rat sensory neurons. Eur J Pharmacol 436: 151-158.
28. Risau W (1997). Mechanisms of angiogenesis. Nature 386: 671-674.
29. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB et al. (1997). Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99: 2429-2437.
30. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I (1994). Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 17: 635-639.
31. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW et al. (2004). Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110: 1219-1225.
32. Shibata S (2001). Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16 (Suppl): S28-S37.
33. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K et al. (1997). Endothelial dysfunction associated with a disruptive mutation in the estrogen receptor gene. Lancet 349: 1146-1147.
34. Tombran-Tink J (2005). The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 10: 2131-2149.
35. Tombran-Tink J, Lara N, Apricio SE, Potluri P, Gee S, Ma JX et al. (2004). Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp Eye Res 78: 945-955.
36. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E et al. (1996). Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 2: 11.
37. Venkov CD, Rankin AB, Vaughan DE (1996). Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94: 727-733.
38. Wang A, Wang CZ, Wu JA, Osinski J, Yuan CS (2005). Determination of major ginsenosides in Panax quinquefolius (American ginseng) using high-performance liquid chromatography. Phytochem Anal 16: 272-277.
39. Yue PY, Wong DY, Wu PK, Leung PY, Mak NK, Yeung HW et al. (2006). The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 72: 437-445.
40. Yun TK (2003). Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523-524: 63-74.
41. Zhu S, Zou K, Fushimi H, Cal S, Komatsu K (2004). Comparative study on triterpene saponins of Ginseng drugs. Planta Med 70: 666-677.